The Food and Drug Administration will meet later this month to consider Johnson & Johnson's request for approval of the world's first single-dose COVID-19 vaccine. WWJ's Brooke Allen talked with Dr. Matthew Sims, Director of Infectious Diseases Research at Beaumont Health.